Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia

• Main Authors: Ibrahim Turkoz (Author), Joshua Wong (Author), Benjamin Chee (Author), Uzma Siddiqui (Author), R. Karl Knight (Author), Ute Richarz (Author), Christoph U. Correll (Author)
• Format: Book
• Published: SAGE Publishing, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The paliperidone palmitate 6-month (PP6M) long-acting injectable formulation is currently the longest dosing interval available for schizophrenia treatment. Objective: To compare treatment outcomes between a real-world external comparator arm (ECA; NeuroBlu database) and the PP6M open-la...